However, uterine cancer is a much rarer form of cancer than breast cancer. The drug also increases the risk of blood clots travelling to the lungs, a rare but dangerous condition. Continued on page 4 Promising new therapy may double survival rates for malignant melanoma immune system defenses to attack cancerous cells. Maxamine enhances the immune response to destroy tumor cells. In clinical trials to date, Maxamine has more than doubled patient survival and disease free remission rates.
Clinical trials are an important method of identifying and evaluating new treatments.
Each patient who participates provides valuable information on the effectiveness of the new therapy. Quite simply, without clinical trials there would be little hope for new and more effective medicines to combat this and other cancers. Malignant melanoma patients are urged to ask their physicians to contact the nearest trial site for more information. Continued on page 4 A new treatment that could improve survival for people with advanced skin cancer called malignant melanoma is in the final stages of testing and may offer a highly promising option to the more than 150,000 Americans afflicted with this disease. The treatment, called Maxamine therapy, harnesses the body's own immune system to combat malignant melanoma.